Frequently Asked Questions About 2697.HK

What does Guangdong True Health Medical Technology Development Co., Ltd. do?

Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

What is 2697.HK's market cap?

Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) has a market capitalization of approximately $17.18 billion, as of July 21, 2026, based on the most recent share price and shares outstanding.

Does 2697.HK pay a dividend?

No — Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

Is 2697.HK profitable?

Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

2697.HK (Guangdong True Health Medical Technology Development Co., Ltd.) is a recent IPO.

It began trading on June 30, 2026, giving it less than a month of public history. Many charts and metrics below are sparse or empty until more price, financial, and analyst history accumulates — the affected sections are flagged individually so you can tell limited history from missing data.

2697.HK

Guangdong True Health Medical Technology Development Co., Ltd.

HKSE·Medical, Devices · Healthcare

HK$482.00HK$30.80+6.83%

Market capHK$17.18B·Jul 21 8:08 AM UTC

Price Chart

HK$482.00+HK$30.80 (+6.83%)today

+20.50%

Select date range

FromTo

Jun 30, 2026Jun 30, 2026 → Jul 21, 2026· 21 daysJul 21, 2026

Key Metrics

2697.HK does not currently pay a dividend.

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how 2697.HK's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for 2697.HK and 80,000+ other tickers.

About Guangdong True Health Medical Technology Development Co., Ltd.

Guangdong True Health Medical Technology Development Co., Ltd. engages in in the research and development, manufacture and sale of surgical robots and disposables in the People's Republic of China and Hong Kong. The company offers products, such as percutaneous puncture surgery robots, includes TH-S1, TH-S, TH-S Pro and TH-SA; microwave ablation surgical robot for the treatment of liver and lung tumors; percutaneous microwave ablation surgical robot TH-X HMW approved for the treatment of liver tumors; AI-based 3D reconstruction software for medical imaging; and five additional product…

CEO: Hou Iam Cheong
Sector: Healthcare
Industry: Medical - Devices
Exchange: HKSE
Employees: 156
Website: www.truehealth.cn

Latest News

News Tab

No recent news available.

Frequently Asked Questions About 2697.HK

What does Guangdong True Health Medical Technology Development Co., Ltd. do?: Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) operates in the Medical - Devices industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.
What is 2697.HK's market cap?: Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) has a market capitalization of approximately $17.18 billion, as of July 21, 2026, based on the most recent share price and shares outstanding.
Does 2697.HK pay a dividend?: No — Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.
Is 2697.HK profitable?: Guangdong True Health Medical Technology Development Co., Ltd. (2697.HK) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.